Protective effects of osthole against myocardial ischemia/reperfusion injury in rats

International Journal of Molecular Medicine

Volumn 32, Issue 2, 2013, Pages 365-372

  Wang, Xian Yue ^a   Dong, Wen Peng ^a   Bi, Sheng Hui ^a   Pan, Zhi Guo ^a   Yu, Hao ^a   Wang, Xiao Wu ^a   Ma, Tao ^a   Wang, Jun ^a   Zhang, Wei Da ^a  

^a GUANGZHOU GENERAL HOSPITAL OF GUANGZHOU MILITARY COMMAND   (China)

Author keywords

Anti inflammation; Cardioprotection; Ischemia reperfusion; Osthole

Indexed keywords

CREATINE KINASE MB; GLUTATHIONE PEROXIDASE; INTERLEUKIN 10; INTERLEUKIN 6; LACTATE DEHYDROGENASE; OSTHOLE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG DOSE COMPARISON; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART HEMODYNAMICS; HEART INFARCTION; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE RELAXATION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART RATE; LIPID PEROXIDATION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; WESTERN BLOTTING;

ANIMALS; CALCIUM CHANNEL BLOCKERS; CATALASE; COUMARINS; CYTOKINES; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; HEMODYNAMICS; HMGB1 PROTEIN; INFLAMMATION MEDIATORS; LIPID PEROXIDATION; MALE; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NF-KAPPA B; OXIDATIVE STRESS; RATS; SUPEROXIDE DISMUTASE;

EID: 84879349770     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2013.1386     Document Type: Article

References (50)

1. Thom T, Haase N, Rosamond W, et al: Heart disease and stroke statistics-2006 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 113: E85-e151, 2006.
2. Lloyd-Jones D, Adams RJ, Brown TM, et al: Heart disease and stroke statistics-2010 update: A report from the American Heart Association. Circulation 121: E46-e215, 2010.
3. Renda G and de Caterina R: Impact of antiplatelet therapy in heart disease. Adv Cardiol 47: 5-19, 2012.
4. Gnecchi M, Danieli P and Cervio E: Mesenchymal stem cell therapy for heart disease. Vascul Pharmacol 57: 48-55, 2012.
5. Songco AV and Brener SJ: Initial strategy of revascularization versus optimal medical therapy for improving outcomes in ischemic heart disease: A review of the literature. Curr Cardiol Rep 14: 397-407, 2012.
6. Ji X, Tan BK, Zhu YC, Linz W and Zhu YZ: Comparison of cardioprotective effects using ramipril and DanShen for the treatment of acute myocardial infarction in rats. Life Sci 73: 1413-1426, 2003. (Pubitemid 36794583)
7. Bolli R, Becker L, Gross G, Mentzer R Jr, Balshaw D and Lathrop DA: Myocardial protection at a crossroads: The need for translation into clinical therapy. Circ Res 95: 125-134, 2004. (Pubitemid 38988678)
8. Sun J, Tan BK, Huang SH, Whiteman M and Zhu YZ: Effects of natural products on ischemic heart diseases and cardiovascular system. Acta Pharmacol Sin 23: 1142-1151, 2002. (Pubitemid 35470339)
9. He H, Xu J, Xu Y, et al: Cardioprotective effects of saponins from Panax japonicus on acute myocardial ischemia against oxidative stress-triggered damage and cardiac cell death in rats. J Ethnopharmacol 140: 73-82, 2012.
10. Ko FN, Wu TS, Liou MJ, Huang TF and Teng CM: Vasorelaxation of rat thoracic aorta caused by osthole isolated from Angelica pubescens. Eur J Pharmacol 219: 29-34, 1992.
11. Huang RL, Chen CC, Huang YL, et al: Osthole increases glycosylation of hepatitis B surface antigen and suppresses the secretion of hepatitis B virus in vitro. Hepatology 24: 508-515, 1996.
12. Liu JH, Zschocke S, Reininger E and Bauer R: Inhibitory effects of Angelica pubescens f. biserrata on 5-lipoxygenase and cyclooxygenase. Planta Med 64: 525-529, 1998. (Pubitemid 28383885)
13. Xu XM, Zhang Y, Qu D, Feng XW, Chen Y and Zhao L: Osthole suppresses migration and invasion of A549 human lung cancer cells through inhibition of matrix metalloproteinase-2 and matrix metallopeptidase-9 in vitro. Mol Med Rep 6: 1018-1022, 2012.
14. Lin VC, Chou CH, Lin YC, et al: Osthole suppresses fatty acid synthase expression in HER2-overexpressing breast cancer cells through modulating Akt/mTOR pathway. J Agric Food Chem 58: 4786-4793, 2010.
15. Okamoto T, Kawasaki T and Hino O: Osthole prevents anti-Fas antibody-induced hepatitis in mice by affecting the caspase3-mediated apoptotic pathway. Biochem Pharmacol 65: 677-681, 2003. (Pubitemid 36144255)
16. Li XX, Hara I and Matsumiya T: Effects of osthole on postmenopausal osteoporosis using ovariectomized rats; comparison to the effects of estradiol. Biol Pharm Bull 25: 738-742, 2002. (Pubitemid 40036708)
17. Matsuda H, Tomohiro N, Ido Y and Kubo M: Anti-allergic effects of Cnidii Monnieri Fructus (dried fruits of Cnidium monnieri) and its major component, osthol. Biol Pharm Bull 25: 809-812, 2002. (Pubitemid 40036723)
18. Chao X, Zhou J, Chen T, et al: Neuroprotective effect of osthole against acute ischemic stroke on middle cerebral ischemia occlusion in rats. Brain Res 1363: 206-211, 2010.
19. Chen T, Liu W, Chao X, et al: Neuroprotective effect of osthole against oxygen and glucose deprivation in rat cortical neurons: Involvement of mitogen-activated protein kinase pathway. Neuroscience 183: 203-211, 2011.
20. Lee YS, Kang YJ, Kim HJ, et al: Higenamine reduces apoptotic cell death by induction of heme oxygenase-1 in rat myocardial ischemia-reperfusion injury. Apoptosis 11: 1091-1100, 2006. (Pubitemid 44035958)
21. Hwa JS, Jin YC, Lee YS, et al: 2-methoxycinnamaldehyde from Cinnamomum cassia reduces rat myocardial ischemia and reperfusion injury in vivo due to HO-1 induction. J Ethnopharmacol 139: 605-615, 2012.
22. Raedschelders K, Ansley DM and Chen DD: The cellular and molecular origin of reactive oxygen species generation during myocardial ischemia and reperfusion. Pharmacol Ther 133: 230-255, 2012.
23. Sanada S, Komuro I and Kitakaze M: Pathophysiology of myocardial reperfusion injury: Preconditioning, postconditioning, and translational aspects of protective measures. Am J Physiol Heart Circ Physiol 301: H1723-H1741, 2011.
24. Garcia-Dorado D, Agullo L, Sartorio CL and Ruiz-Meana M: Myocardial protection against reperfusion injury: The cGMP pathway. Thromb Haemost 101: 635-642, 2009.
25. Bell RM and Yellon DM: There is more to life than revascularization: Therapeutic targeting of myocardial ischemia/reperfusion injury. Cardiovasc Ther 29: E67-e79, 2011.
26. Akhlaghi M and Bandy B: Mechanisms of flavonoid protection against myocardial ischemia-reperfusion injury. J Mol Cell Cardiol 46: 309-317, 2009.
27. Rakotovao A, Berthonneche C, Guiraud A, et al: Ethanol, wine, and experimental cardioprotection in ischemia/reperfusion: Role of the prooxidant/antioxidant balance. Antioxid Redox Signal 6: 431-438, 2004. (Pubitemid 38332601)
28. Wu J, Hecker JG and Chiamvimonvat N: Antioxidant enzyme gene transfer for ischemic diseases. Adv Drug Deliv Rev 61: 351-363, 2009.
29. Limon-Pacheco J and Gonsebatt ME: The role of antioxidants and antioxidant-related enzymes in protective responses to environmentally induced oxidative stress. Mutat Res 674: 137-147, 2009.
30. He SQ, Zhang YH, Venugopal SK, et al: Delivery of antioxidative enzyme genes protects against ischemia/reperfusion-induced liver injury in mice. Liver Transpl 12: 1869-1879, 2006. (Pubitemid 44911814)
31. Hoehn B, Yenari MA, Sapolsky RM and Steinberg GK: Glutathione peroxidase overexpression inhibits cytochrome C release and proapoptotic mediators to protect neurons from experimental stroke. Stroke 34: 2489-2494, 2003. (Pubitemid 37221970)
32. Zhu JW, Chen T, Guan J, Liu WB and Liu J: Neuroprotective effects of allicin on spinal cord ischemia-reperfusion injury via improvement of mitochondrial function in rabbits. Neurochem Int 61: 640-648, 2012.
33. Ye R, Yang Q, Kong X, et al: Ginsenoside Rd attenuates early oxidative damage and sequential inflammatory response after transient focal ischemia in rats. Neurochem Int 58: 391-398, 2011.
34. Frangogiannis NG, Smith CW and Entman ML: The inflammatory response in myocardial infarction. Cardiovasc Res 53: 31-47, 2002. (Pubitemid 34020764)
35. Yellon DM and Hausenloy DJ: Myocardial reperfusion injury. N Engl J Med 357: 1121-1135, 2007.
36. Jordan JE, Zhao ZQ and Vinten-Johansen J: The role of neutrophils in myocardial ischemia-reperfusion injury. Cardiovasc Res 43: 860-878, 1999. (Pubitemid 29413185)
37. Steffens S, Montecucco F and Mach F: The inflammatory response as a target to reduce myocardial ischaemia and reperfusion injury. Thromb Haemost 102: 240-247, 2009.
38. Frangogiannis NG: Chemokines in ischemia and reperfusion. Thromb Haemost 97: 738-747, 2007. (Pubitemid 46779959)
39. Chen T, Liu W, Chao X, et al: Salvianolic acid B attenuates brain damage and inflammation after traumatic brain injury in mice. Brain Res Bull 84: 163-168, 2011.
40. Chandrasekar B and Freeman GL: Induction of nuclear factor kappaB and activation protein 1 in postischemic myocardium. FEBS Lett 401: 30-34, 1997. (Pubitemid 27051252)
41. Chandrasekar B, Colston JT and Freeman GL: Induction of proinflammatory cytokine and antioxidant enzyme gene expression following brief myocardial ischaemia. Clin Exp Immunol 108: 346-351, 1997. (Pubitemid 27223477)
42. Li C, Gao Y, Xing Y, Zhu H, Shen J and Tian J: Fucoidan, a sulfated polysaccharide from brown algae, against myocardial ischemia-reperfusion injury in rats via regulating the inflammation response. Food Chem Toxicol 49: 2090-2095, 2011.
43. Lotze MT and Tracey KJ: High-mobility group box 1 protein (HMGB1): Nuclear weapon in the immune arsenal. Nat Rev Immunol 5: 331-342, 2005. (Pubitemid 40516158)
44. Yang H and Tracey KJ: Targeting HMGB1 in inflammation. Biochim Biophys Acta 1799: 149-156, 2010.
45. Andrassy M, Volz HC, Igwe JC, et al: High-mobility group box-1 in ischemia-reperfusion injury of the heart. Circulation 117: 3216-3226, 2008.
46. Schmidt AM, Yan SD, Yan SF and Stern DM: The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J Clin Invest 108: 949-955, 2001. (Pubitemid 32946067)
47. Volz HC, Kaya Z, Katus HA and Andrassy M: The role of HMGB1/RAGE in inflammatory cardiomyopathy. Semin Thromb Hemost 36: 185-194, 2010.
48. Tsung A, Sahai R, Tanaka H, et al: The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J Exp Med 201: 1135-1143, 2005. (Pubitemid 40524681)
49. Jiang WL, Zhang SP, Zhu HB and Hou J: Cardioprotection of Asperosaponin X on experimental myocardial ischemia injury. Int J Cardiol 155: 430-436, 2012.
50. Kang ZC, Jiang WL, Xu Y, Zhu HB and Hou J: Cardioprotection with 8-O-acetyl shanzhiside methylester on experimental myocardial ischemia injury. Eur J Pharm Sci 47: 124-130, 2012.